COVID-19 Impact on Global Viral Vector & Plasmid DNA Manufacturing Market Size, Status and Forecast 2020-2026
![](/report_cover/6975/covid-19-impact-on-global-viral-vector-plasmid-dna-manufacturing-market-size-status-n-forecast-2020-2026_en.gif)
This report focuses on the global Viral Vector & Plasmid DNA Manufacturing status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Viral Vector & Plasmid DNA Manufacturing development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
The key players covered in this study
The key players covered in this study
- Merck
- uniQure
- The Cell and Gene Therapy Catapult
- Waisman Biomanufacturing
- Addgene
- Creative Biogene
- Novasep
- Cobra Biologics
- Aldevron
- Adenovirus
- Retrovirus
- Plasmid DNA
- Others
- Biopharmaceutical Companies
- Research Institutes
- North America
- Europe
- China
- Japan
- Southeast Asia
- India
- Central & South America
- To analyze global Viral Vector & Plasmid DNA Manufacturing status, future forecast, growth opportunity, key market and key players.
- To present the Viral Vector & Plasmid DNA Manufacturing development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
- To strategically profile the key players and comprehensively analyze their development plan and strategies.
- To define, describe and forecast the market by type, market and key regions.
- History Year: 2015-2019
- Base Year: 2019
- Estimated Year: 2020
- Forecast Year 2020 to 2026
1 REPORT OVERVIEW
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Viral Vector & Plasmid DNA Manufacturing Revenue
1.4 Market Analysis by Type
1.4.1 Global Viral Vector & Plasmid DNA Manufacturing Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Adenovirus
1.4.3 Retrovirus
1.4.4 Plasmid DNA
1.4.5 Others
1.5 Market by Application
1.5.1 Global Viral Vector & Plasmid DNA Manufacturing Market Share by Application: 2020 VS 2026
1.5.2 Biopharmaceutical Companies
1.5.3 Research Institutes
1.6 Coronavirus Disease 2019 (Covid-19): Viral Vector & Plasmid DNA Manufacturing Industry Impact
1.6.1 How the Covid-19 is Affecting the Viral Vector & Plasmid DNA Manufacturing Industry
1.6.1.1 Viral Vector & Plasmid DNA Manufacturing Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Viral Vector & Plasmid DNA Manufacturing Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Viral Vector & Plasmid DNA Manufacturing Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 GLOBAL GROWTH TRENDS BY REGIONS
2.1 Viral Vector & Plasmid DNA Manufacturing Market Perspective (2015-2026)
2.2 Viral Vector & Plasmid DNA Manufacturing Growth Trends by Regions
2.2.1 Viral Vector & Plasmid DNA Manufacturing Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Viral Vector & Plasmid DNA Manufacturing Historic Market Share by Regions (2015-2020)
2.2.3 Viral Vector & Plasmid DNA Manufacturing Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Viral Vector & Plasmid DNA Manufacturing Market Growth Strategy
2.3.6 Primary Interviews with Key Viral Vector & Plasmid DNA Manufacturing Players (Opinion Leaders)
3 COMPETITION LANDSCAPE BY KEY PLAYERS
3.1 Global Top Viral Vector & Plasmid DNA Manufacturing Players by Market Size
3.1.1 Global Top Viral Vector & Plasmid DNA Manufacturing Players by Revenue (2015-2020)
3.1.2 Global Viral Vector & Plasmid DNA Manufacturing Revenue Market Share by Players (2015-2020)
3.1.3 Global Viral Vector & Plasmid DNA Manufacturing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Viral Vector & Plasmid DNA Manufacturing Market Concentration Ratio
3.2.1 Global Viral Vector & Plasmid DNA Manufacturing Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Viral Vector & Plasmid DNA Manufacturing Revenue in 2019
3.3 Viral Vector & Plasmid DNA Manufacturing Key Players Head office and Area Served
3.4 Key Players Viral Vector & Plasmid DNA Manufacturing Product Solution and Service
3.5 Date of Enter into Viral Vector & Plasmid DNA Manufacturing Market
3.6 Mergers & Acquisitions, Expansion Plans
4 BREAKDOWN DATA BY TYPE (2015-2026)
4.1 Global Viral Vector & Plasmid DNA Manufacturing Historic Market Size by Type (2015-2020)
4.2 Global Viral Vector & Plasmid DNA Manufacturing Forecasted Market Size by Type (2021-2026)
5 VIRAL VECTOR & PLASMID DNA MANUFACTURING BREAKDOWN DATA BY APPLICATION (2015-2026)
5.1 Global Viral Vector & Plasmid DNA Manufacturing Market Size by Application (2015-2020)
5.2 Global Viral Vector & Plasmid DNA Manufacturing Forecasted Market Size by Application (2021-2026)
6 NORTH AMERICA
6.1 North America Viral Vector & Plasmid DNA Manufacturing Market Size (2015-2020)
6.2 Viral Vector & Plasmid DNA Manufacturing Key Players in North America (2019-2020)
6.3 North America Viral Vector & Plasmid DNA Manufacturing Market Size by Type (2015-2020)
6.4 North America Viral Vector & Plasmid DNA Manufacturing Market Size by Application (2015-2020)
7 EUROPE
7.1 Europe Viral Vector & Plasmid DNA Manufacturing Market Size (2015-2020)
7.2 Viral Vector & Plasmid DNA Manufacturing Key Players in Europe (2019-2020)
7.3 Europe Viral Vector & Plasmid DNA Manufacturing Market Size by Type (2015-2020)
7.4 Europe Viral Vector & Plasmid DNA Manufacturing Market Size by Application (2015-2020)
8 CHINA
8.1 China Viral Vector & Plasmid DNA Manufacturing Market Size (2015-2020)
8.2 Viral Vector & Plasmid DNA Manufacturing Key Players in China (2019-2020)
8.3 China Viral Vector & Plasmid DNA Manufacturing Market Size by Type (2015-2020)
8.4 China Viral Vector & Plasmid DNA Manufacturing Market Size by Application (2015-2020)
9 JAPAN
9.1 Japan Viral Vector & Plasmid DNA Manufacturing Market Size (2015-2020)
9.2 Viral Vector & Plasmid DNA Manufacturing Key Players in Japan (2019-2020)
9.3 Japan Viral Vector & Plasmid DNA Manufacturing Market Size by Type (2015-2020)
9.4 Japan Viral Vector & Plasmid DNA Manufacturing Market Size by Application (2015-2020)
10 SOUTHEAST ASIA
10.1 Southeast Asia Viral Vector & Plasmid DNA Manufacturing Market Size (2015-2020)
10.2 Viral Vector & Plasmid DNA Manufacturing Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Viral Vector & Plasmid DNA Manufacturing Market Size by Type (2015-2020)
10.4 Southeast Asia Viral Vector & Plasmid DNA Manufacturing Market Size by Application (2015-2020)
11 INDIA
11.1 India Viral Vector & Plasmid DNA Manufacturing Market Size (2015-2020)
11.2 Viral Vector & Plasmid DNA Manufacturing Key Players in India (2019-2020)
11.3 India Viral Vector & Plasmid DNA Manufacturing Market Size by Type (2015-2020)
11.4 India Viral Vector & Plasmid DNA Manufacturing Market Size by Application (2015-2020)
12 CENTRAL & SOUTH AMERICA
12.1 Central & South America Viral Vector & Plasmid DNA Manufacturing Market Size (2015-2020)
12.2 Viral Vector & Plasmid DNA Manufacturing Key Players in Central & South America (2019-2020)
12.3 Central & South America Viral Vector & Plasmid DNA Manufacturing Market Size by Type (2015-2020)
12.4 Central & South America Viral Vector & Plasmid DNA Manufacturing Market Size by Application (2015-2020)
13 KEY PLAYERS PROFILES
13.1 Merck
13.1.1 Merck Company Details
13.1.2 Merck Business Overview and Its Total Revenue
13.1.3 Merck Viral Vector & Plasmid DNA Manufacturing Introduction
13.1.4 Merck Revenue in Viral Vector & Plasmid DNA Manufacturing Business (2015-2020))
13.1.5 Merck Recent Development
13.2 uniQure
13.2.1 uniQure Company Details
13.2.2 uniQure Business Overview and Its Total Revenue
13.2.3 uniQure Viral Vector & Plasmid DNA Manufacturing Introduction
13.2.4 uniQure Revenue in Viral Vector & Plasmid DNA Manufacturing Business (2015-2020)
13.2.5 uniQure Recent Development
13.3 The Cell and Gene Therapy Catapult
13.3.1 The Cell and Gene Therapy Catapult Company Details
13.3.2 The Cell and Gene Therapy Catapult Business Overview and Its Total Revenue
13.3.3 The Cell and Gene Therapy Catapult Viral Vector & Plasmid DNA Manufacturing Introduction
13.3.4 The Cell and Gene Therapy Catapult Revenue in Viral Vector & Plasmid DNA Manufacturing Business (2015-2020)
13.3.5 The Cell and Gene Therapy Catapult Recent Development
13.4 Waisman Biomanufacturing
13.4.1 Waisman Biomanufacturing Company Details
13.4.2 Waisman Biomanufacturing Business Overview and Its Total Revenue
13.4.3 Waisman Biomanufacturing Viral Vector & Plasmid DNA Manufacturing Introduction
13.4.4 Waisman Biomanufacturing Revenue in Viral Vector & Plasmid DNA Manufacturing Business (2015-2020)
13.4.5 Waisman Biomanufacturing Recent Development
13.5 Addgene
13.5.1 Addgene Company Details
13.5.2 Addgene Business Overview and Its Total Revenue
13.5.3 Addgene Viral Vector & Plasmid DNA Manufacturing Introduction
13.5.4 Addgene Revenue in Viral Vector & Plasmid DNA Manufacturing Business (2015-2020)
13.5.5 Addgene Recent Development
13.6 Creative Biogene
13.6.1 Creative Biogene Company Details
13.6.2 Creative Biogene Business Overview and Its Total Revenue
13.6.3 Creative Biogene Viral Vector & Plasmid DNA Manufacturing Introduction
13.6.4 Creative Biogene Revenue in Viral Vector & Plasmid DNA Manufacturing Business (2015-2020)
13.6.5 Creative Biogene Recent Development
13.7 Novasep
13.7.1 Novasep Company Details
13.7.2 Novasep Business Overview and Its Total Revenue
13.7.3 Novasep Viral Vector & Plasmid DNA Manufacturing Introduction
13.7.4 Novasep Revenue in Viral Vector & Plasmid DNA Manufacturing Business (2015-2020)
13.7.5 Novasep Recent Development
13.8 Cobra Biologics
13.8.1 Cobra Biologics Company Details
13.8.2 Cobra Biologics Business Overview and Its Total Revenue
13.8.3 Cobra Biologics Viral Vector & Plasmid DNA Manufacturing Introduction
13.8.4 Cobra Biologics Revenue in Viral Vector & Plasmid DNA Manufacturing Business (2015-2020)
13.8.5 Cobra Biologics Recent Development
13.9 Aldevron
13.9.1 Aldevron Company Details
13.9.2 Aldevron Business Overview and Its Total Revenue
13.9.3 Aldevron Viral Vector & Plasmid DNA Manufacturing Introduction
13.9.4 Aldevron Revenue in Viral Vector & Plasmid DNA Manufacturing Business (2015-2020)
13.9.5 Aldevron Recent Development
14 ANALYST'S VIEWPOINTS/CONCLUSIONS
15 APPENDIX
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Viral Vector & Plasmid DNA Manufacturing Revenue
1.4 Market Analysis by Type
1.4.1 Global Viral Vector & Plasmid DNA Manufacturing Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Adenovirus
1.4.3 Retrovirus
1.4.4 Plasmid DNA
1.4.5 Others
1.5 Market by Application
1.5.1 Global Viral Vector & Plasmid DNA Manufacturing Market Share by Application: 2020 VS 2026
1.5.2 Biopharmaceutical Companies
1.5.3 Research Institutes
1.6 Coronavirus Disease 2019 (Covid-19): Viral Vector & Plasmid DNA Manufacturing Industry Impact
1.6.1 How the Covid-19 is Affecting the Viral Vector & Plasmid DNA Manufacturing Industry
1.6.1.1 Viral Vector & Plasmid DNA Manufacturing Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Viral Vector & Plasmid DNA Manufacturing Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Viral Vector & Plasmid DNA Manufacturing Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 GLOBAL GROWTH TRENDS BY REGIONS
2.1 Viral Vector & Plasmid DNA Manufacturing Market Perspective (2015-2026)
2.2 Viral Vector & Plasmid DNA Manufacturing Growth Trends by Regions
2.2.1 Viral Vector & Plasmid DNA Manufacturing Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Viral Vector & Plasmid DNA Manufacturing Historic Market Share by Regions (2015-2020)
2.2.3 Viral Vector & Plasmid DNA Manufacturing Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Viral Vector & Plasmid DNA Manufacturing Market Growth Strategy
2.3.6 Primary Interviews with Key Viral Vector & Plasmid DNA Manufacturing Players (Opinion Leaders)
3 COMPETITION LANDSCAPE BY KEY PLAYERS
3.1 Global Top Viral Vector & Plasmid DNA Manufacturing Players by Market Size
3.1.1 Global Top Viral Vector & Plasmid DNA Manufacturing Players by Revenue (2015-2020)
3.1.2 Global Viral Vector & Plasmid DNA Manufacturing Revenue Market Share by Players (2015-2020)
3.1.3 Global Viral Vector & Plasmid DNA Manufacturing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Viral Vector & Plasmid DNA Manufacturing Market Concentration Ratio
3.2.1 Global Viral Vector & Plasmid DNA Manufacturing Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Viral Vector & Plasmid DNA Manufacturing Revenue in 2019
3.3 Viral Vector & Plasmid DNA Manufacturing Key Players Head office and Area Served
3.4 Key Players Viral Vector & Plasmid DNA Manufacturing Product Solution and Service
3.5 Date of Enter into Viral Vector & Plasmid DNA Manufacturing Market
3.6 Mergers & Acquisitions, Expansion Plans
4 BREAKDOWN DATA BY TYPE (2015-2026)
4.1 Global Viral Vector & Plasmid DNA Manufacturing Historic Market Size by Type (2015-2020)
4.2 Global Viral Vector & Plasmid DNA Manufacturing Forecasted Market Size by Type (2021-2026)
5 VIRAL VECTOR & PLASMID DNA MANUFACTURING BREAKDOWN DATA BY APPLICATION (2015-2026)
5.1 Global Viral Vector & Plasmid DNA Manufacturing Market Size by Application (2015-2020)
5.2 Global Viral Vector & Plasmid DNA Manufacturing Forecasted Market Size by Application (2021-2026)
6 NORTH AMERICA
6.1 North America Viral Vector & Plasmid DNA Manufacturing Market Size (2015-2020)
6.2 Viral Vector & Plasmid DNA Manufacturing Key Players in North America (2019-2020)
6.3 North America Viral Vector & Plasmid DNA Manufacturing Market Size by Type (2015-2020)
6.4 North America Viral Vector & Plasmid DNA Manufacturing Market Size by Application (2015-2020)
7 EUROPE
7.1 Europe Viral Vector & Plasmid DNA Manufacturing Market Size (2015-2020)
7.2 Viral Vector & Plasmid DNA Manufacturing Key Players in Europe (2019-2020)
7.3 Europe Viral Vector & Plasmid DNA Manufacturing Market Size by Type (2015-2020)
7.4 Europe Viral Vector & Plasmid DNA Manufacturing Market Size by Application (2015-2020)
8 CHINA
8.1 China Viral Vector & Plasmid DNA Manufacturing Market Size (2015-2020)
8.2 Viral Vector & Plasmid DNA Manufacturing Key Players in China (2019-2020)
8.3 China Viral Vector & Plasmid DNA Manufacturing Market Size by Type (2015-2020)
8.4 China Viral Vector & Plasmid DNA Manufacturing Market Size by Application (2015-2020)
9 JAPAN
9.1 Japan Viral Vector & Plasmid DNA Manufacturing Market Size (2015-2020)
9.2 Viral Vector & Plasmid DNA Manufacturing Key Players in Japan (2019-2020)
9.3 Japan Viral Vector & Plasmid DNA Manufacturing Market Size by Type (2015-2020)
9.4 Japan Viral Vector & Plasmid DNA Manufacturing Market Size by Application (2015-2020)
10 SOUTHEAST ASIA
10.1 Southeast Asia Viral Vector & Plasmid DNA Manufacturing Market Size (2015-2020)
10.2 Viral Vector & Plasmid DNA Manufacturing Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Viral Vector & Plasmid DNA Manufacturing Market Size by Type (2015-2020)
10.4 Southeast Asia Viral Vector & Plasmid DNA Manufacturing Market Size by Application (2015-2020)
11 INDIA
11.1 India Viral Vector & Plasmid DNA Manufacturing Market Size (2015-2020)
11.2 Viral Vector & Plasmid DNA Manufacturing Key Players in India (2019-2020)
11.3 India Viral Vector & Plasmid DNA Manufacturing Market Size by Type (2015-2020)
11.4 India Viral Vector & Plasmid DNA Manufacturing Market Size by Application (2015-2020)
12 CENTRAL & SOUTH AMERICA
12.1 Central & South America Viral Vector & Plasmid DNA Manufacturing Market Size (2015-2020)
12.2 Viral Vector & Plasmid DNA Manufacturing Key Players in Central & South America (2019-2020)
12.3 Central & South America Viral Vector & Plasmid DNA Manufacturing Market Size by Type (2015-2020)
12.4 Central & South America Viral Vector & Plasmid DNA Manufacturing Market Size by Application (2015-2020)
13 KEY PLAYERS PROFILES
13.1 Merck
13.1.1 Merck Company Details
13.1.2 Merck Business Overview and Its Total Revenue
13.1.3 Merck Viral Vector & Plasmid DNA Manufacturing Introduction
13.1.4 Merck Revenue in Viral Vector & Plasmid DNA Manufacturing Business (2015-2020))
13.1.5 Merck Recent Development
13.2 uniQure
13.2.1 uniQure Company Details
13.2.2 uniQure Business Overview and Its Total Revenue
13.2.3 uniQure Viral Vector & Plasmid DNA Manufacturing Introduction
13.2.4 uniQure Revenue in Viral Vector & Plasmid DNA Manufacturing Business (2015-2020)
13.2.5 uniQure Recent Development
13.3 The Cell and Gene Therapy Catapult
13.3.1 The Cell and Gene Therapy Catapult Company Details
13.3.2 The Cell and Gene Therapy Catapult Business Overview and Its Total Revenue
13.3.3 The Cell and Gene Therapy Catapult Viral Vector & Plasmid DNA Manufacturing Introduction
13.3.4 The Cell and Gene Therapy Catapult Revenue in Viral Vector & Plasmid DNA Manufacturing Business (2015-2020)
13.3.5 The Cell and Gene Therapy Catapult Recent Development
13.4 Waisman Biomanufacturing
13.4.1 Waisman Biomanufacturing Company Details
13.4.2 Waisman Biomanufacturing Business Overview and Its Total Revenue
13.4.3 Waisman Biomanufacturing Viral Vector & Plasmid DNA Manufacturing Introduction
13.4.4 Waisman Biomanufacturing Revenue in Viral Vector & Plasmid DNA Manufacturing Business (2015-2020)
13.4.5 Waisman Biomanufacturing Recent Development
13.5 Addgene
13.5.1 Addgene Company Details
13.5.2 Addgene Business Overview and Its Total Revenue
13.5.3 Addgene Viral Vector & Plasmid DNA Manufacturing Introduction
13.5.4 Addgene Revenue in Viral Vector & Plasmid DNA Manufacturing Business (2015-2020)
13.5.5 Addgene Recent Development
13.6 Creative Biogene
13.6.1 Creative Biogene Company Details
13.6.2 Creative Biogene Business Overview and Its Total Revenue
13.6.3 Creative Biogene Viral Vector & Plasmid DNA Manufacturing Introduction
13.6.4 Creative Biogene Revenue in Viral Vector & Plasmid DNA Manufacturing Business (2015-2020)
13.6.5 Creative Biogene Recent Development
13.7 Novasep
13.7.1 Novasep Company Details
13.7.2 Novasep Business Overview and Its Total Revenue
13.7.3 Novasep Viral Vector & Plasmid DNA Manufacturing Introduction
13.7.4 Novasep Revenue in Viral Vector & Plasmid DNA Manufacturing Business (2015-2020)
13.7.5 Novasep Recent Development
13.8 Cobra Biologics
13.8.1 Cobra Biologics Company Details
13.8.2 Cobra Biologics Business Overview and Its Total Revenue
13.8.3 Cobra Biologics Viral Vector & Plasmid DNA Manufacturing Introduction
13.8.4 Cobra Biologics Revenue in Viral Vector & Plasmid DNA Manufacturing Business (2015-2020)
13.8.5 Cobra Biologics Recent Development
13.9 Aldevron
13.9.1 Aldevron Company Details
13.9.2 Aldevron Business Overview and Its Total Revenue
13.9.3 Aldevron Viral Vector & Plasmid DNA Manufacturing Introduction
13.9.4 Aldevron Revenue in Viral Vector & Plasmid DNA Manufacturing Business (2015-2020)
13.9.5 Aldevron Recent Development
14 ANALYST'S VIEWPOINTS/CONCLUSIONS
15 APPENDIX
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
LIST OF TABLES
Table 1. Viral Vector & Plasmid DNA Manufacturing Key Market Segments
Table 2. Key Players Covered: Ranking by Viral Vector & Plasmid DNA Manufacturing Revenue
Table 3. Ranking of Global Top Viral Vector & Plasmid DNA Manufacturing Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Viral Vector & Plasmid DNA Manufacturing Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Adenovirus
Table 6. Key Players of Retrovirus
Table 7. Key Players of Plasmid DNA
Table 8. Key Players of Others
Table 9. COVID-19 Impact Global Market: (Four Viral Vector & Plasmid DNA Manufacturing Market Size Forecast Scenarios)
Table 10. Opportunities and Trends for Viral Vector & Plasmid DNA Manufacturing Players in the COVID-19 Landscape
Table 11. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 12. Key Regions/Countries Measures against Covid-19 Impact
Table 13. Proposal for Viral Vector & Plasmid DNA Manufacturing Players to Combat Covid-19 Impact
Table 14. Global Viral Vector & Plasmid DNA Manufacturing Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 15. Global Viral Vector & Plasmid DNA Manufacturing Market Size by Regions (US$ Million): 2020 VS 2026
Table 16. Global Viral Vector & Plasmid DNA Manufacturing Market Size by Regions (2015-2020) (US$ Million)
Table 17. Global Viral Vector & Plasmid DNA Manufacturing Market Share by Regions (2015-2020)
Table 18. Global Viral Vector & Plasmid DNA Manufacturing Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 19. Global Viral Vector & Plasmid DNA Manufacturing Market Share by Regions (2021-2026)
Table 20. Market Top Trends
Table 21. Key Drivers: Impact Analysis
Table 22. Key Challenges
Table 23. Viral Vector & Plasmid DNA Manufacturing Market Growth Strategy
Table 24. Main Points Interviewed from Key Viral Vector & Plasmid DNA Manufacturing Players
Table 25. Global Viral Vector & Plasmid DNA Manufacturing Revenue by Players (2015-2020) (Million US$)
Table 26. Global Viral Vector & Plasmid DNA Manufacturing Market Share by Players (2015-2020)
Table 27. Global Top Viral Vector & Plasmid DNA Manufacturing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Viral Vector & Plasmid DNA Manufacturing as of 2019)
Table 28. Global Viral Vector & Plasmid DNA Manufacturing by Players Market Concentration Ratio (CR5 and HHI)
Table 29. Key Players Headquarters and Area Served
Table 30. Key Players Viral Vector & Plasmid DNA Manufacturing Product Solution and Service
Table 31. Date of Enter into Viral Vector & Plasmid DNA Manufacturing Market
Table 32. Mergers & Acquisitions, Expansion Plans
Table 33. Global Viral Vector & Plasmid DNA Manufacturing Market Size by Type (2015-2020) (Million US$)
Table 34. Global Viral Vector & Plasmid DNA Manufacturing Market Size Share by Type (2015-2020)
Table 35. Global Viral Vector & Plasmid DNA Manufacturing Revenue Market Share by Type (2021-2026)
Table 36. Global Viral Vector & Plasmid DNA Manufacturing Market Size Share by Application (2015-2020)
Table 37. Global Viral Vector & Plasmid DNA Manufacturing Market Size by Application (2015-2020) (Million US$)
Table 38. Global Viral Vector & Plasmid DNA Manufacturing Market Size Share by Application (2021-2026)
Table 39. North America Key Players Viral Vector & Plasmid DNA Manufacturing Revenue (2019-2020) (Million US$)
Table 40. North America Key Players Viral Vector & Plasmid DNA Manufacturing Market Share (2019-2020)
Table 41. North America Viral Vector & Plasmid DNA Manufacturing Market Size by Type (2015-2020) (Million US$)
Table 42. North America Viral Vector & Plasmid DNA Manufacturing Market Share by Type (2015-2020)
Table 43. North America Viral Vector & Plasmid DNA Manufacturing Market Size by Application (2015-2020) (Million US$)
Table 44. North America Viral Vector & Plasmid DNA Manufacturing Market Share by Application (2015-2020)
Table 45. Europe Key Players Viral Vector & Plasmid DNA Manufacturing Revenue (2019-2020) (Million US$)
Table 46. Europe Key Players Viral Vector & Plasmid DNA Manufacturing Market Share (2019-2020)
Table 47. Europe Viral Vector & Plasmid DNA Manufacturing Market Size by Type (2015-2020) (Million US$)
Table 48. Europe Viral Vector & Plasmid DNA Manufacturing Market Share by Type (2015-2020)
Table 49. Europe Viral Vector & Plasmid DNA Manufacturing Market Size by Application (2015-2020) (Million US$)
Table 50. Europe Viral Vector & Plasmid DNA Manufacturing Market Share by Application (2015-2020)
Table 51. China Key Players Viral Vector & Plasmid DNA Manufacturing Revenue (2019-2020) (Million US$)
Table 52. China Key Players Viral Vector & Plasmid DNA Manufacturing Market Share (2019-2020)
Table 53. China Viral Vector & Plasmid DNA Manufacturing Market Size by Type (2015-2020) (Million US$)
Table 54. China Viral Vector & Plasmid DNA Manufacturing Market Share by Type (2015-2020)
Table 55. China Viral Vector & Plasmid DNA Manufacturing Market Size by Application (2015-2020) (Million US$)
Table 56. China Viral Vector & Plasmid DNA Manufacturing Market Share by Application (2015-2020)
Table 57. Japan Key Players Viral Vector & Plasmid DNA Manufacturing Revenue (2019-2020) (Million US$)
Table 58. Japan Key Players Viral Vector & Plasmid DNA Manufacturing Market Share (2019-2020)
Table 59. Japan Viral Vector & Plasmid DNA Manufacturing Market Size by Type (2015-2020) (Million US$)
Table 60. Japan Viral Vector & Plasmid DNA Manufacturing Market Share by Type (2015-2020)
Table 61. Japan Viral Vector & Plasmid DNA Manufacturing Market Size by Application (2015-2020) (Million US$)
Table 62. Japan Viral Vector & Plasmid DNA Manufacturing Market Share by Application (2015-2020)
Table 63. Southeast Asia Key Players Viral Vector & Plasmid DNA Manufacturing Revenue (2019-2020) (Million US$)
Table 64. Southeast Asia Key Players Viral Vector & Plasmid DNA Manufacturing Market Share (2019-2020)
Table 65. Southeast Asia Viral Vector & Plasmid DNA Manufacturing Market Size by Type (2015-2020) (Million US$)
Table 66. Southeast Asia Viral Vector & Plasmid DNA Manufacturing Market Share by Type (2015-2020)
Table 67. Southeast Asia Viral Vector & Plasmid DNA Manufacturing Market Size by Application (2015-2020) (Million US$)
Table 68. Southeast Asia Viral Vector & Plasmid DNA Manufacturing Market Share by Application (2015-2020)
Table 69. India Key Players Viral Vector & Plasmid DNA Manufacturing Revenue (2019-2020) (Million US$)
Table 70. India Key Players Viral Vector & Plasmid DNA Manufacturing Market Share (2019-2020)
Table 71. India Viral Vector & Plasmid DNA Manufacturing Market Size by Type (2015-2020) (Million US$)
Table 72. India Viral Vector & Plasmid DNA Manufacturing Market Share by Type (2015-2020)
Table 73. India Viral Vector & Plasmid DNA Manufacturing Market Size by Application (2015-2020) (Million US$)
Table 74. India Viral Vector & Plasmid DNA Manufacturing Market Share by Application (2015-2020)
Table 75. Central & South America Key Players Viral Vector & Plasmid DNA Manufacturing Revenue (2019-2020) (Million US$)
Table 76. Central & South America Key Players Viral Vector & Plasmid DNA Manufacturing Market Share (2019-2020)
Table 77. Central & South America Viral Vector & Plasmid DNA Manufacturing Market Size by Type (2015-2020) (Million US$)
Table 78. Central & South America Viral Vector & Plasmid DNA Manufacturing Market Share by Type (2015-2020)
Table 79. Central & South America Viral Vector & Plasmid DNA Manufacturing Market Size by Application (2015-2020) (Million US$)
Table 80. Central & South America Viral Vector & Plasmid DNA Manufacturing Market Share by Application (2015-2020)
Table 81. Merck Company Details
Table 82. Merck Business Overview
Table 83. Merck Product
Table 84. Merck Revenue in Viral Vector & Plasmid DNA Manufacturing Business (2015-2020) (Million US$)
Table 85. Merck Recent Development
Table 86. uniQure Company Details
Table 87. uniQure Business Overview
Table 88. uniQure Product
Table 89. uniQure Revenue in Viral Vector & Plasmid DNA Manufacturing Business (2015-2020) (Million US$)
Table 90. uniQure Recent Development
Table 91. The Cell and Gene Therapy Catapult Company Details
Table 92. The Cell and Gene Therapy Catapult Business Overview
Table 93. The Cell and Gene Therapy Catapult Product
Table 94. The Cell and Gene Therapy Catapult Revenue in Viral Vector & Plasmid DNA Manufacturing Business (2015-2020) (Million US$)
Table 95. The Cell and Gene Therapy Catapult Recent Development
Table 96. Waisman Biomanufacturing Company Details
Table 97. Waisman Biomanufacturing Business Overview
Table 98. Waisman Biomanufacturing Product
Table 99. Waisman Biomanufacturing Revenue in Viral Vector & Plasmid DNA Manufacturing Business (2015-2020) (Million US$)
Table 100. Waisman Biomanufacturing Recent Development
Table 101. Addgene Company Details
Table 102. Addgene Business Overview
Table 103. Addgene Product
Table 104. Addgene Revenue in Viral Vector & Plasmid DNA Manufacturing Business (2015-2020) (Million US$)
Table 105. Addgene Recent Development
Table 106. Creative Biogene Company Details
Table 107. Creative Biogene Business Overview
Table 108. Creative Biogene Product
Table 109. Creative Biogene Revenue in Viral Vector & Plasmid DNA Manufacturing Business (2015-2020) (Million US$)
Table 110. Creative Biogene Recent Development
Table 111. Novasep Company Details
Table 112. Novasep Business Overview
Table 113. Novasep Product
Table 114. Novasep Revenue in Viral Vector & Plasmid DNA Manufacturing Business (2015-2020) (Million US$)
Table 115. Novasep Recent Development
Table 116. Cobra Biologics Business Overview
Table 117. Cobra Biologics Product
Table 118. Cobra Biologics Company Details
Table 119. Cobra Biologics Revenue in Viral Vector & Plasmid DNA Manufacturing Business (2015-2020) (Million US$)
Table 120. Cobra Biologics Recent Development
Table 121. Aldevron Company Details
Table 122. Aldevron Business Overview
Table 123. Aldevron Product
Table 124. Aldevron Revenue in Viral Vector & Plasmid DNA Manufacturing Business (2015-2020) (Million US$)
Table 125. Aldevron Recent Development
Table 126. Research Programs/Design for This Report
Table 127. Key Data Information from Secondary Sources
Table 128. Key Data Information from Primary Sources
Table 1. Viral Vector & Plasmid DNA Manufacturing Key Market Segments
Table 2. Key Players Covered: Ranking by Viral Vector & Plasmid DNA Manufacturing Revenue
Table 3. Ranking of Global Top Viral Vector & Plasmid DNA Manufacturing Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Viral Vector & Plasmid DNA Manufacturing Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Adenovirus
Table 6. Key Players of Retrovirus
Table 7. Key Players of Plasmid DNA
Table 8. Key Players of Others
Table 9. COVID-19 Impact Global Market: (Four Viral Vector & Plasmid DNA Manufacturing Market Size Forecast Scenarios)
Table 10. Opportunities and Trends for Viral Vector & Plasmid DNA Manufacturing Players in the COVID-19 Landscape
Table 11. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 12. Key Regions/Countries Measures against Covid-19 Impact
Table 13. Proposal for Viral Vector & Plasmid DNA Manufacturing Players to Combat Covid-19 Impact
Table 14. Global Viral Vector & Plasmid DNA Manufacturing Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 15. Global Viral Vector & Plasmid DNA Manufacturing Market Size by Regions (US$ Million): 2020 VS 2026
Table 16. Global Viral Vector & Plasmid DNA Manufacturing Market Size by Regions (2015-2020) (US$ Million)
Table 17. Global Viral Vector & Plasmid DNA Manufacturing Market Share by Regions (2015-2020)
Table 18. Global Viral Vector & Plasmid DNA Manufacturing Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 19. Global Viral Vector & Plasmid DNA Manufacturing Market Share by Regions (2021-2026)
Table 20. Market Top Trends
Table 21. Key Drivers: Impact Analysis
Table 22. Key Challenges
Table 23. Viral Vector & Plasmid DNA Manufacturing Market Growth Strategy
Table 24. Main Points Interviewed from Key Viral Vector & Plasmid DNA Manufacturing Players
Table 25. Global Viral Vector & Plasmid DNA Manufacturing Revenue by Players (2015-2020) (Million US$)
Table 26. Global Viral Vector & Plasmid DNA Manufacturing Market Share by Players (2015-2020)
Table 27. Global Top Viral Vector & Plasmid DNA Manufacturing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Viral Vector & Plasmid DNA Manufacturing as of 2019)
Table 28. Global Viral Vector & Plasmid DNA Manufacturing by Players Market Concentration Ratio (CR5 and HHI)
Table 29. Key Players Headquarters and Area Served
Table 30. Key Players Viral Vector & Plasmid DNA Manufacturing Product Solution and Service
Table 31. Date of Enter into Viral Vector & Plasmid DNA Manufacturing Market
Table 32. Mergers & Acquisitions, Expansion Plans
Table 33. Global Viral Vector & Plasmid DNA Manufacturing Market Size by Type (2015-2020) (Million US$)
Table 34. Global Viral Vector & Plasmid DNA Manufacturing Market Size Share by Type (2015-2020)
Table 35. Global Viral Vector & Plasmid DNA Manufacturing Revenue Market Share by Type (2021-2026)
Table 36. Global Viral Vector & Plasmid DNA Manufacturing Market Size Share by Application (2015-2020)
Table 37. Global Viral Vector & Plasmid DNA Manufacturing Market Size by Application (2015-2020) (Million US$)
Table 38. Global Viral Vector & Plasmid DNA Manufacturing Market Size Share by Application (2021-2026)
Table 39. North America Key Players Viral Vector & Plasmid DNA Manufacturing Revenue (2019-2020) (Million US$)
Table 40. North America Key Players Viral Vector & Plasmid DNA Manufacturing Market Share (2019-2020)
Table 41. North America Viral Vector & Plasmid DNA Manufacturing Market Size by Type (2015-2020) (Million US$)
Table 42. North America Viral Vector & Plasmid DNA Manufacturing Market Share by Type (2015-2020)
Table 43. North America Viral Vector & Plasmid DNA Manufacturing Market Size by Application (2015-2020) (Million US$)
Table 44. North America Viral Vector & Plasmid DNA Manufacturing Market Share by Application (2015-2020)
Table 45. Europe Key Players Viral Vector & Plasmid DNA Manufacturing Revenue (2019-2020) (Million US$)
Table 46. Europe Key Players Viral Vector & Plasmid DNA Manufacturing Market Share (2019-2020)
Table 47. Europe Viral Vector & Plasmid DNA Manufacturing Market Size by Type (2015-2020) (Million US$)
Table 48. Europe Viral Vector & Plasmid DNA Manufacturing Market Share by Type (2015-2020)
Table 49. Europe Viral Vector & Plasmid DNA Manufacturing Market Size by Application (2015-2020) (Million US$)
Table 50. Europe Viral Vector & Plasmid DNA Manufacturing Market Share by Application (2015-2020)
Table 51. China Key Players Viral Vector & Plasmid DNA Manufacturing Revenue (2019-2020) (Million US$)
Table 52. China Key Players Viral Vector & Plasmid DNA Manufacturing Market Share (2019-2020)
Table 53. China Viral Vector & Plasmid DNA Manufacturing Market Size by Type (2015-2020) (Million US$)
Table 54. China Viral Vector & Plasmid DNA Manufacturing Market Share by Type (2015-2020)
Table 55. China Viral Vector & Plasmid DNA Manufacturing Market Size by Application (2015-2020) (Million US$)
Table 56. China Viral Vector & Plasmid DNA Manufacturing Market Share by Application (2015-2020)
Table 57. Japan Key Players Viral Vector & Plasmid DNA Manufacturing Revenue (2019-2020) (Million US$)
Table 58. Japan Key Players Viral Vector & Plasmid DNA Manufacturing Market Share (2019-2020)
Table 59. Japan Viral Vector & Plasmid DNA Manufacturing Market Size by Type (2015-2020) (Million US$)
Table 60. Japan Viral Vector & Plasmid DNA Manufacturing Market Share by Type (2015-2020)
Table 61. Japan Viral Vector & Plasmid DNA Manufacturing Market Size by Application (2015-2020) (Million US$)
Table 62. Japan Viral Vector & Plasmid DNA Manufacturing Market Share by Application (2015-2020)
Table 63. Southeast Asia Key Players Viral Vector & Plasmid DNA Manufacturing Revenue (2019-2020) (Million US$)
Table 64. Southeast Asia Key Players Viral Vector & Plasmid DNA Manufacturing Market Share (2019-2020)
Table 65. Southeast Asia Viral Vector & Plasmid DNA Manufacturing Market Size by Type (2015-2020) (Million US$)
Table 66. Southeast Asia Viral Vector & Plasmid DNA Manufacturing Market Share by Type (2015-2020)
Table 67. Southeast Asia Viral Vector & Plasmid DNA Manufacturing Market Size by Application (2015-2020) (Million US$)
Table 68. Southeast Asia Viral Vector & Plasmid DNA Manufacturing Market Share by Application (2015-2020)
Table 69. India Key Players Viral Vector & Plasmid DNA Manufacturing Revenue (2019-2020) (Million US$)
Table 70. India Key Players Viral Vector & Plasmid DNA Manufacturing Market Share (2019-2020)
Table 71. India Viral Vector & Plasmid DNA Manufacturing Market Size by Type (2015-2020) (Million US$)
Table 72. India Viral Vector & Plasmid DNA Manufacturing Market Share by Type (2015-2020)
Table 73. India Viral Vector & Plasmid DNA Manufacturing Market Size by Application (2015-2020) (Million US$)
Table 74. India Viral Vector & Plasmid DNA Manufacturing Market Share by Application (2015-2020)
Table 75. Central & South America Key Players Viral Vector & Plasmid DNA Manufacturing Revenue (2019-2020) (Million US$)
Table 76. Central & South America Key Players Viral Vector & Plasmid DNA Manufacturing Market Share (2019-2020)
Table 77. Central & South America Viral Vector & Plasmid DNA Manufacturing Market Size by Type (2015-2020) (Million US$)
Table 78. Central & South America Viral Vector & Plasmid DNA Manufacturing Market Share by Type (2015-2020)
Table 79. Central & South America Viral Vector & Plasmid DNA Manufacturing Market Size by Application (2015-2020) (Million US$)
Table 80. Central & South America Viral Vector & Plasmid DNA Manufacturing Market Share by Application (2015-2020)
Table 81. Merck Company Details
Table 82. Merck Business Overview
Table 83. Merck Product
Table 84. Merck Revenue in Viral Vector & Plasmid DNA Manufacturing Business (2015-2020) (Million US$)
Table 85. Merck Recent Development
Table 86. uniQure Company Details
Table 87. uniQure Business Overview
Table 88. uniQure Product
Table 89. uniQure Revenue in Viral Vector & Plasmid DNA Manufacturing Business (2015-2020) (Million US$)
Table 90. uniQure Recent Development
Table 91. The Cell and Gene Therapy Catapult Company Details
Table 92. The Cell and Gene Therapy Catapult Business Overview
Table 93. The Cell and Gene Therapy Catapult Product
Table 94. The Cell and Gene Therapy Catapult Revenue in Viral Vector & Plasmid DNA Manufacturing Business (2015-2020) (Million US$)
Table 95. The Cell and Gene Therapy Catapult Recent Development
Table 96. Waisman Biomanufacturing Company Details
Table 97. Waisman Biomanufacturing Business Overview
Table 98. Waisman Biomanufacturing Product
Table 99. Waisman Biomanufacturing Revenue in Viral Vector & Plasmid DNA Manufacturing Business (2015-2020) (Million US$)
Table 100. Waisman Biomanufacturing Recent Development
Table 101. Addgene Company Details
Table 102. Addgene Business Overview
Table 103. Addgene Product
Table 104. Addgene Revenue in Viral Vector & Plasmid DNA Manufacturing Business (2015-2020) (Million US$)
Table 105. Addgene Recent Development
Table 106. Creative Biogene Company Details
Table 107. Creative Biogene Business Overview
Table 108. Creative Biogene Product
Table 109. Creative Biogene Revenue in Viral Vector & Plasmid DNA Manufacturing Business (2015-2020) (Million US$)
Table 110. Creative Biogene Recent Development
Table 111. Novasep Company Details
Table 112. Novasep Business Overview
Table 113. Novasep Product
Table 114. Novasep Revenue in Viral Vector & Plasmid DNA Manufacturing Business (2015-2020) (Million US$)
Table 115. Novasep Recent Development
Table 116. Cobra Biologics Business Overview
Table 117. Cobra Biologics Product
Table 118. Cobra Biologics Company Details
Table 119. Cobra Biologics Revenue in Viral Vector & Plasmid DNA Manufacturing Business (2015-2020) (Million US$)
Table 120. Cobra Biologics Recent Development
Table 121. Aldevron Company Details
Table 122. Aldevron Business Overview
Table 123. Aldevron Product
Table 124. Aldevron Revenue in Viral Vector & Plasmid DNA Manufacturing Business (2015-2020) (Million US$)
Table 125. Aldevron Recent Development
Table 126. Research Programs/Design for This Report
Table 127. Key Data Information from Secondary Sources
Table 128. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Global Viral Vector & Plasmid DNA Manufacturing Market Share by Type: 2020 VS 2026
Figure 2. Adenovirus Features
Figure 3. Retrovirus Features
Figure 4. Plasmid DNA Features
Figure 5. Others Features
Figure 6. Global Viral Vector & Plasmid DNA Manufacturing Market Share by Application: 2020 VS 2026
Figure 7. Biopharmaceutical Companies Case Studies
Figure 8. Research Institutes Case Studies
Figure 9. Viral Vector & Plasmid DNA Manufacturing Report Years Considered
Figure 10. Global Viral Vector & Plasmid DNA Manufacturing Market Size YoY Growth 2015-2026 (US$ Million)
Figure 11. Global Viral Vector & Plasmid DNA Manufacturing Market Share by Regions: 2020 VS 2026
Figure 12. Global Viral Vector & Plasmid DNA Manufacturing Market Share by Regions (2021-2026)
Figure 13. Porter's Five Forces Analysis
Figure 14. Global Viral Vector & Plasmid DNA Manufacturing Market Share by Players in 2019
Figure 15. Global Top Viral Vector & Plasmid DNA Manufacturing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Viral Vector & Plasmid DNA Manufacturing as of 2019
Figure 16. The Top 10 and 5 Players Market Share by Viral Vector & Plasmid DNA Manufacturing Revenue in 2019
Figure 17. North America Viral Vector & Plasmid DNA Manufacturing Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Europe Viral Vector & Plasmid DNA Manufacturing Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. China Viral Vector & Plasmid DNA Manufacturing Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Japan Viral Vector & Plasmid DNA Manufacturing Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Southeast Asia Viral Vector & Plasmid DNA Manufacturing Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. India Viral Vector & Plasmid DNA Manufacturing Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Central & South America Viral Vector & Plasmid DNA Manufacturing Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Merck Total Revenue (US$ Million): 2019 Compared with 2018
Figure 25. Merck Revenue Growth Rate in Viral Vector & Plasmid DNA Manufacturing Business (2015-2020)
Figure 26. uniQure Total Revenue (US$ Million): 2019 Compared with 2018
Figure 27. uniQure Revenue Growth Rate in Viral Vector & Plasmid DNA Manufacturing Business (2015-2020)
Figure 28. The Cell and Gene Therapy Catapult Total Revenue (US$ Million): 2019 Compared with 2018
Figure 29. The Cell and Gene Therapy Catapult Revenue Growth Rate in Viral Vector & Plasmid DNA Manufacturing Business (2015-2020)
Figure 30. Waisman Biomanufacturing Total Revenue (US$ Million): 2019 Compared with 2018
Figure 31. Waisman Biomanufacturing Revenue Growth Rate in Viral Vector & Plasmid DNA Manufacturing Business (2015-2020)
Figure 32. Addgene Total Revenue (US$ Million): 2019 Compared with 2018
Figure 33. Addgene Revenue Growth Rate in Viral Vector & Plasmid DNA Manufacturing Business (2015-2020)
Figure 34. Creative Biogene Total Revenue (US$ Million): 2019 Compared with 2018
Figure 35. Creative Biogene Revenue Growth Rate in Viral Vector & Plasmid DNA Manufacturing Business (2015-2020)
Figure 36. Novasep Total Revenue (US$ Million): 2019 Compared with 2018
Figure 37. Novasep Revenue Growth Rate in Viral Vector & Plasmid DNA Manufacturing Business (2015-2020)
Figure 38. Cobra Biologics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 39. Cobra Biologics Revenue Growth Rate in Viral Vector & Plasmid DNA Manufacturing Business (2015-2020)
Figure 40. Aldevron Total Revenue (US$ Million): 2019 Compared with 2018
Figure 41. Aldevron Revenue Growth Rate in Viral Vector & Plasmid DNA Manufacturing Business (2015-2020)
Figure 42. Bottom-up and Top-down Approaches for This Report
Figure 43. Data Triangulation
Figure 44. Key Executives Interviewed
Figure 1. Global Viral Vector & Plasmid DNA Manufacturing Market Share by Type: 2020 VS 2026
Figure 2. Adenovirus Features
Figure 3. Retrovirus Features
Figure 4. Plasmid DNA Features
Figure 5. Others Features
Figure 6. Global Viral Vector & Plasmid DNA Manufacturing Market Share by Application: 2020 VS 2026
Figure 7. Biopharmaceutical Companies Case Studies
Figure 8. Research Institutes Case Studies
Figure 9. Viral Vector & Plasmid DNA Manufacturing Report Years Considered
Figure 10. Global Viral Vector & Plasmid DNA Manufacturing Market Size YoY Growth 2015-2026 (US$ Million)
Figure 11. Global Viral Vector & Plasmid DNA Manufacturing Market Share by Regions: 2020 VS 2026
Figure 12. Global Viral Vector & Plasmid DNA Manufacturing Market Share by Regions (2021-2026)
Figure 13. Porter's Five Forces Analysis
Figure 14. Global Viral Vector & Plasmid DNA Manufacturing Market Share by Players in 2019
Figure 15. Global Top Viral Vector & Plasmid DNA Manufacturing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Viral Vector & Plasmid DNA Manufacturing as of 2019
Figure 16. The Top 10 and 5 Players Market Share by Viral Vector & Plasmid DNA Manufacturing Revenue in 2019
Figure 17. North America Viral Vector & Plasmid DNA Manufacturing Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Europe Viral Vector & Plasmid DNA Manufacturing Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. China Viral Vector & Plasmid DNA Manufacturing Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Japan Viral Vector & Plasmid DNA Manufacturing Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Southeast Asia Viral Vector & Plasmid DNA Manufacturing Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. India Viral Vector & Plasmid DNA Manufacturing Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Central & South America Viral Vector & Plasmid DNA Manufacturing Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Merck Total Revenue (US$ Million): 2019 Compared with 2018
Figure 25. Merck Revenue Growth Rate in Viral Vector & Plasmid DNA Manufacturing Business (2015-2020)
Figure 26. uniQure Total Revenue (US$ Million): 2019 Compared with 2018
Figure 27. uniQure Revenue Growth Rate in Viral Vector & Plasmid DNA Manufacturing Business (2015-2020)
Figure 28. The Cell and Gene Therapy Catapult Total Revenue (US$ Million): 2019 Compared with 2018
Figure 29. The Cell and Gene Therapy Catapult Revenue Growth Rate in Viral Vector & Plasmid DNA Manufacturing Business (2015-2020)
Figure 30. Waisman Biomanufacturing Total Revenue (US$ Million): 2019 Compared with 2018
Figure 31. Waisman Biomanufacturing Revenue Growth Rate in Viral Vector & Plasmid DNA Manufacturing Business (2015-2020)
Figure 32. Addgene Total Revenue (US$ Million): 2019 Compared with 2018
Figure 33. Addgene Revenue Growth Rate in Viral Vector & Plasmid DNA Manufacturing Business (2015-2020)
Figure 34. Creative Biogene Total Revenue (US$ Million): 2019 Compared with 2018
Figure 35. Creative Biogene Revenue Growth Rate in Viral Vector & Plasmid DNA Manufacturing Business (2015-2020)
Figure 36. Novasep Total Revenue (US$ Million): 2019 Compared with 2018
Figure 37. Novasep Revenue Growth Rate in Viral Vector & Plasmid DNA Manufacturing Business (2015-2020)
Figure 38. Cobra Biologics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 39. Cobra Biologics Revenue Growth Rate in Viral Vector & Plasmid DNA Manufacturing Business (2015-2020)
Figure 40. Aldevron Total Revenue (US$ Million): 2019 Compared with 2018
Figure 41. Aldevron Revenue Growth Rate in Viral Vector & Plasmid DNA Manufacturing Business (2015-2020)
Figure 42. Bottom-up and Top-down Approaches for This Report
Figure 43. Data Triangulation
Figure 44. Key Executives Interviewed